Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice
Abstract Background Myelin oligodendrocyte glycoprotein-associated disorders (MOGAD) is an autoimmune central nervous system disease. Antigen-specific immune tolerance using nanoparticles such as Polylactic-co-glycolic acid (PLGA) have recently been used as a new therapeutic tolerization approach fo...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-03-01
|
| Schriftenreihe: | BMC Neuroscience |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12868-024-00859-y |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|